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synthesis by DNA lesions
Yuina Sonohara, Shigenori Iwai and Isao Kuraoka*
Abstract
Introduction: A wide variety of DNA lesions such as ultraviolet light-induced photoproducts and chemically
induced bulky adducts and crosslinks (intrastrand and interstrand) interfere with replication and lead to
mutations and cell death. In the human body, these damages may cause cancer, inborn diseases, and aging.
So far, mutation-related actions of DNA polymerases during replication have been intensively studied. However,
DNA lesions also block RNA synthesis, making the detection of their effects on transcription equally important for
chemical safety assessment. Previously, we established an in vivo method for detecting DNA damage induced by
ultraviolet light and/or chemicals via inhibition of RNA polymerase by visualizing transcription.
Results: Here, we present an in vitro method for detecting the effects of chemically induced DNA lesions using in vitro
transcription with T7 RNA polymerase and real-time reverse transcription polymerase chain reaction (PCR) based on
inhibition of in vitro RNA synthesis. Conventional PCR and real-time reverse transcription PCR without in vitro transcription
can detect DNA lesions such as complicated cisplatin DNA adducts but not UV-induced lesions. We found that only this
combination of in vitro transcription and real-time reverse transcription PCR can detect both cisplatin- and UV-induced
DNA lesions that interfere with transcription.
Conclusions: We anticipate that this method will be useful for estimating the potential transcriptional toxicity
of chemicals in terminally differentiated cells engaged in active transcription and translation but not in
replication.
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Introduction
Genomic DNA is continuously damaged by various
exogenous and endogenous agents [1, 2]. The induced
DNA lesions interfere with replication, leading to mu-
tations and cell death, and have been associated with
cancer, inborn diseases, and aging. In addition, DNA
lesions interfere with transcription, inhibiting elong-
ation by RNA polymerase and leading to reduced
transcription and/or mutations of the transcript [3, 4].
Therefore, DNA lesions can induce cytotoxicity by
inhibiting replication and/or transcription.
Under laboratory conditions, cell lines are main-
tained in an environment favorable to growth, DNA
repair, prevention of apoptosis, and other aspects of
cellular metabolism [3, 5–7]. As cancer and stem
cells divide rapidly and constantly, proper experimen-
tal conditions for such cell lines are focused on repli-
cation. However, most cells within the human body
are not exposed to such experimental conditions and
are terminally differentiated, and post-mitotic cells
engage in active transcription and translation but not
in replication. Hence, transcription is assumed to be
as important as replication for estimating the genetic
toxicity of DNA lesions in human organs.
Inhibition of transcription can be effected by RNA
polymerase stalling due to DNA lesions or RNA poly-
merase II inhibitors such as alpha-amanitin from the
death cap [8, 9] and actinomycin D from Streptomyces
bacteria, which intercalate into DNA and activate an in-
ducer of apoptosis in many cell lines [10, 11].
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All known organisms have repair systems to remove
DNA lesions and maintain genomic integrity. When
RNA polymerase II encounters DNA damage that blocks
transcription during the elongation phase, transcription-
coupled repair (TCR) immediately counteracts the
interference. Previous studies have demonstrated TCR
responses to bulky and helix-distorting lesions such as
ultraviolet light (UV)-induced photolesions, e.g., cyclobu-
tane pyrimidine dimers (CPD) [12, 13] and 6–4 photo-
products (6–4 pp) [14], cisplatin intrastrand crosslinks
[15], and benzopyrene adducts [16].
Assessment of the biological risk and toxicity of
newly synthesized chemicals is hampered by the large
number of substances and the complexities of living
cells. Current methods for detecting toxic substances
are based on the DNA damage response in replication
and cell proliferation. For example, the micronucleus
assay that detects small nuclei is a well-established
method for monitoring genetic toxicity of test sub-
stances in the environment [17], and the comet assay
(single-cell gel electrophoresis) is a simple and sensi-
tive method for measuring chemically induced DNA
damage [18, 19]. Despite the availability of numerous
assays to detect genotoxic chemicals, there was no
simple method to estimate their effects on transcrip-
tion until recently.
In our previous work, we established a method for
detecting the effects of chemically induced DNA dam-
age on transcription using the nucleotide analog 5-


























Fig. 1 Experimental design. a In the absence of DNA damage, RNA polymerase generates RNA transcripts from DNA templates (normal transcription).
After purifying RNA, RT-PCR is performed, and the PCR products are analyzed. b If chemical substances damage DNA, the resulting lesions inhibit RNA
synthesis, as RNA polymerase cannot synthesize transcripts from damaged templates, and PCR products will not be detected
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or the nucleotide analog 5-ethynyluridine [20] and a
click chemistry reaction [21, 22] without radioisotopes
[23]. Our method is based on a model for transcription-
coupled nucleotide excision repair (NER) triggered by
blocked transcription at DNA lesions [24, 25]. The method
employs common human cells without genetic modifica-
tions and terminally differentiated PC12 cells that actively
undergo transcription but not replication, and it can
detect a wide range of DNA lesions within 8 h of
exposure to UV and/or chemicals, e.g., camptothecin,
etoposide, 4-nitroquinoline 1-oxide (4NQO), mitomy-
cin, and cisplatin.
Here we present an in vitro assay for detecting the ef-
fects of chemically induced DNA lesions using in vitro
transcription and real-time reverse transcription poly-
merase chain reaction (PCR). The method is based on
the inhibition of in vitro RNA synthesis for chemically
treated DNA templates and allows evaluation of the po-
tential effects of chemicals on transcription in termin-
ally differentiated human cells.
Materials and methods
Enzymes and chemicals
T7 RNA polymerase (T7 RNAP) and reverse transcript-
ase were purchased from TOYOBO (Osaka, Japan).
RNase inhibitor was from Wako (Osaka, Japan), restric-
tion enzymes were from New England Biolabs (Ipswich,
MA, USA), Fast SYBR Green Master Mix was from Life
Technologies (Carlsbad, CA, USA), and cisplatin was
from Sigma-Aldrich (St. Louis, MO, USA).
DNA treatment
Plasmid (pBluescript II SK (−) containing the T7 pro-
moter; Stratagene, La Jolla, CA, USA) DNA templates
were purified using the QIAGEN Midi Kit (QIAGEN,
Hilden, Germany). For UV irradiation of DNA tem-
plates, UV-light (254 nm, 450 J/m2) was used. For
cisplatin treatment, DNA templates were incubated
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Fig. 2 Analysis of PCR products from UV-irradiated DNA templates. a Scheme for detecting DNA damage using PCR products from
UV-irradiated (450 J/m2) DNA templates. b Agarose gel (1 %) demonstrating PCR products (301 bp) from UV-irradiated DNA templates.
M: size marker. Odd lanes: PCR products from mock DNA templates. Even lanes: PCR products from UV-irradiated DNA templates. DNA
was amplified for 9 (lanes 1 and 2), 12 (lanes 3 and 4), 15 (lanes 5 and 6), 18 (lanes 7 and 8), or 21 (lanes 9 and 10) PCR cycles
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Fig. 3 Analysis of PCR products generated by RT-PCR from RNA transcripts of UV-irradiated DNA templates. a Scheme for detecting transcription
inhibition using RNA transcripts from UV-irradiated (450 J/m2) DNA templates. b Agarose gel (1 %) demonstrating RNA transcripts from UV-irradiated DNA
templates. M: size marker. Lane 1: RNA transcripts from mock DNA templates. Lane 2: RNA transcripts from UV-irradiated DNA templates. c Agarose gel
(1 %) demonstrating RT-PCR products (301 bp) from UV-irradiated DNA templates. M: size marker. Odd lanes: RT-PCR products from mock DNA templates.
Even lanes: RT-PCR products from UV-irradiated DNA templates. DNA was amplified for 9 (lanes 1 and 2), 12 (lanes 3 and 4), 15 (lanes 5 and 6), 18 (lanes 7
and 8), or 21 (lanes 9 and 10) PCR cycles. Lanes 11 and 12: no RT reaction
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Polymerase chain reaction (PCR)
For PCR, UV-irradiated or cisplatin-treated DNA sam-
ples were used with primers 2140–2159 (5′-tatcagcaataa
accagcca-3′) and 2440–2421 (5′-gcggccaacttacttctgac-3′)
and EmeraldAmp PCR Master Mix (TaKaRa, Otsu,
Shiga, Japan) according to the manufacturer’s instruc-
tions. PCR products were analyzed by 1 % agarose gel
electrophoresis.
In vitro transcription
For in vitro transcription, 50-μL reactions containing
100 ng DNA template, 4 mM NTP mixture (ATP, CTP,
GTP, and UTP), and 5 units thermo T7 RNAP in buffer
(40 mM Tris–HCl, pH 8.0, 50 mM NaCl, 8 mM MgCl2,
5 mM dithiothreitol, 20 units RNase inhibitor) were in-
cubated at 37 °C for 1 h. RNA transcripts were purified
using an RNeasy Mini Kit (QIAGEN) with RNase-Free
DNase (QIAGEN) according to the manufacturer’s in-
structions. Transcription products were analyzed by 1 %
agarose gel electrophoresis.
Reverse transcription (RT)-PCR
cDNAs were generated from purified RNA samples
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Fig. 4 RT-qPCR analysis of transcripts from UV-irradiated DNA templates. a Scheme for detecting transcription inhibition from UV-irradiated
(450 J/m2) DNA templates. b Melting curve of RT-qPCR products from RNA transcripts of UV-irradiated DNA templates. Each reaction was run in
triplicate. c Amplification plot of RT-qPCR analysis of RNA transcripts of UV-irradiated DNA templates. Each reaction was run in triplicate. d Relative
fold change of transcripts from mock (set as 1.0) and UV-irradiated DNA templates. Data show the mean of three samples ± standard
deviation (SD)
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and ReverTra Ace reverse transcriptase (TOYOBO) ac-
cording to the manufacturer’s instructions.
Real-time quantitative PCR (qPCR)
Real-time quantitative PCR (qPCR) was performed on a
StepOne System (Life Technologies) using Fast SYBR
Green Master Mix (Life Technologies) with primers 2140–
2159 (5′-tatcagcaataaaccagcca-3′) and 2440–2421 (5′-gcgg
ccaacttacttctgac-3′) to ensure the appearance of a single
product peak (301 bp) from mock mixtures in the melting
curve analysis. Each reaction was run in triplicate, and the
data were plotted as ΔRn versus cycle number.
Results and discussion
Previously, we demonstrated that our in vivo method for
visualizing transcription in mammalian cells can detect
UV- and/or chemically (e.g., camptothecin, etoposide,
4NQO, cisplatin) induced damage in genomic DNA by
inhibiting RNA polymerase during transcription elongation
[20, 22, 23]. Here, we modified this in vivo method to
establish a new in vitro method (Fig. 1) using T7 RNAP
and DNA templates containing a T7 promoter. RNA
polymerase synthesizes new transcripts from a DNA
template, which can be detected by RT-PCR (Fig. 1a).
However, RNA polymerase stops at chemically induced
DNA lesions, and no products are detected by RT-PCR
(Fig. 1b). First, we tested the detection of UV-induced
DNA lesions (e.g., CPD and 6–4 pp that trigger NER)
using conventional PCR. Under these experimental
conditions, approximately 12 DNA lesions were ex-
pected in plasmid DNA [26]. Although 6–4 pp is more
frequently induced than CPD, both lesions are thought
to inhibit mammalian RNA polymerase II transcription
almost completely [14, 27]. However, conventional PCR
(Fig. 2a) could obscure the difference between UV-
irradiated and non-irradiated DNA (Fig. 2b), as Taq
DNA polymerase might synthesize DNA from the




































































Fig. 5 qPCR analysis of UV-irradiated DNA templates. a Scheme for detecting DNA damage using qPCR products from UV-irradiated (450 J/m2)
DNA templates. b Melting curve of qPCR products from UV-irradiated DNA templates. Each reaction was run in triplicate. c Amplification plot of
qPCR analysis of UV-irradiated DNA templates. Each reaction was run in triplicate. d Relative fold change of PCR products from mock (set as 1.0)
and UV-irradiated DNA templates. Data show the mean of three experiments ± standard deviation (SD)
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template and/or beyond UV lesions such as CPD or
6–4 pp in the PCR cycles [28]. In contrast, T7 RNAP
covers the DNA sequence between the T7 promoter
and the PCR-detecting region and shows inefficient
RNA primer extension from arrested RNAs in a single
reaction [29]. This approach seems to be more suitable
for detecting DNA lesions than conventional PCR as it
reveals the effects of DNA lesions on transcription.
When we tested this method to detect transcription
inhibition by DNA lesions in vitro (Fig. 3a), we identified
newly synthesized RNA transcripts (Fig. 3b) and cDNA
products from those transcripts using RT-PCR (Fig. 3c),
but we could not detect any PCR products without using
reverse transcriptase (Fig. 3c, lanes 11 and 12). As shown
in Fig. 3c, the amounts of PCR products (301 bp) from
non-irradiated DNA (UV -) were higher than those from
UV-irradiated DNA (UV +) until 15 PCR cycles (lanes 5
and 6), indicating that UV-induced DNA lesions blocked
RNA synthesis by T7 RNAP. However, after 18 PCR cy-
cles, no difference between RT-PCR products from non-
irradiated and UV-irradiated templates could be detected
(Fig. 3c, lanes 7–10). These results indicate that RT-PCR
using agarose gel electrophoresis for detection (Fig. 3a)
might not be suitable for determining the effects of UV-
induced DNA damage on transcription because it is ne-
cessary to optimize the number of PCR cycles.
Therefore, we tested the utility of qPCR for detecting
RNA transcription inhibition by UV-induced DNA le-
sions (Fig. 4a). qPCR is both powerful and sensitive and
is used for a broad range of applications. Combined with
reverse transcription, it can quantify RNA in cells or tis-
sues. To adapt the new qPCR method, we first assessed
primer sets using melting curve analysis (Fig. 4b) and
confirmed that these primers generated one PCR prod-
uct under our experimental conditions. This primer de-
sign is a crucial step because inefficient or non-specific
primer annealing will negatively affect the quality and
reliability of the assay. The amplification plot of the
qPCR analysis showed a delay in the accumulation of
qPCR products to later cycles, indicating fewer RNA
transcripts from UV-irradiated templates (Fig. 4c).
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Fig. 6 Analysis of PCR products generated from cisplatin-treated DNA templates. a Scheme for detecting DNA damage using PCR products
from cisplatin-treated DNA templates (drug/nucleotide ratio = 0.005). b Agarose gel (1 %) demonstrating PCR products (301 bp) from cisplatin-
treated DNA templates. M: size marker. Odd lanes: PCR products from mock DNA templates. Even lanes: PCR products from UV-irradiated DNA
templates. DNA was amplified for 9 (lanes 1 and 2), 12 (lanes 3 and 4), 15 (lanes 5 and 6), 18 (lanes 7 and 8), or 21 (lanes 9 and 10) PCR cycles
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of RNA transcripts from UV-irradiated templates was
markedly decreased by 0.052-fold (Fig. 4d). As ex-
pected, qPCR improved detection of the effects of DNA
damage on RNA transcription. Without reverse tran-
scriptase, no specific qPCR products were detected
(Fig. 4c and d), confirming the origin of these products
from T7 RNAP transcription of UV-irradiated DNA
templates. Considering the melting curves shown in
Fig. 4c and d, however, we cannot rule out the possibil-
ity that PCR products derived from DNA remaining
after RNA purification. As qPCR proved suitable for
detecting damaged DNA templates, we tried to directly
apply this method to UV-irradiated templates (Fig. 5).
However, while the amplification plot showed slight
differences, the method was not sensitive enough to
significantly detect damage of UV-irradiated DNA tem-
plates (Fig. 5c and d).
Next, we used cisplatin to directly induce DNA ad-
ducts [30, 31] as intrastrand or interstrand crosslinks
and monoadducts, which interfere with replication
and transcription. Although these adducts are mainly
eliminated by NER [32], they are thought to mediate
the cytotoxic activity of cisplatin in tumor cells. Using
cisplatin-treated DNA samples, we investigated the
generation of PCR products from damaged templates.
Unlike with UV-damaged templates, conventional PCR
(Fig. 6a) revealed differences between cisplatin-treated
and untreated DNA (Fig. 6b). These results suggest that
cisplatin DNA adducts efficiently block DNA synthesis
by Taq DNA polymerase and/or prevent primer anneal-
ing. Consistent with this observation, we obtained simi-
lar results using qPCR to detect cisplatin-induced DNA
adducts, revealing a clear difference between damaged
and non-damaged DNA (Fig. 7).
Previous biochemical studies demonstrated that T7
RNAP stalls at cisplatin DNA adducts [33, 34]. Ac-
cordingly, when we tested the effects of cisplatin on




































































Fig. 7 qPCR analysis of cisplatin-treated DNA templates. a Scheme for detecting DNA damage using PCR products from cisplatin-treated
DNA templates (drug/nucleotide ratio = 0.005). b Melting curve of qPCR products from cisplatin-treated DNA templates. Each reaction
was run in triplicate. c Amplification plot of qPCR analysis of cisplatin-treated DNA templates. Each reaction was run in triplicate. d Relative fold change of
PCR products from mock (set as 1.0) and cisplatin-treated DNA templates. Data show the mean of three experiments ± standard deviation (SD)
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we detected newly synthesized RNA transcripts from
untreated DNA templates (Fig. 8b, lane 1) but not
from cisplatin-treated templates (Fig. 8b, lane 2) and
detected cDNA from untreated DNA templates (Fig. 8c,
lanes 3, 5, 7, and 9) but not cisplatin-treated templates
(Fig. 8c, lanes 4, 6, 8, and 10). No PCR products were
detected in the absence of RT (Fig. 8c, lanes 11 and
12). These results indicate that cisplatin DNA adducts
inhibited T7 RNAP transcription initiation and/or
elongation. qPCR melting curve analysis (Fig. 9a) indi-
cated that the primer set generated one PCR product
after RNA transcription from cisplatin-treated DNA
templates (Fig. 9b), suggesting that the PCR product is
specific. The amplification plot (Fig. 9c) and the relative
fold change (Fig. 9d) showed little T7 RNAP transcrip-
tion of cisplatin-treated DNA templates, and insignifi-
cant amounts of PCR products were generated without
RT, indicating that this method can detect the inhib-
ition of RNA synthesis by cisplatin DNA damage.
Conclusions
In conclusion, conventional PCR and qPCR in the ab-
sence of T7 RNAP transcription can detect chemically
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Fig. 8 Analysis of PCR products generated by RT-PCR from RNA transcripts of cisplatin-treated DNA templates. a Scheme for detecting transcription
inhibition using RNA transcripts from cisplatin-treated DNA templates (drug/nucleotide ratio = 0.005). b Agarose gel (1 %) demonstrating RNA
transcripts from cisplatin-treated DNA templates. M: size marker. Lane 1: RNA transcripts from mock DNA templates. Lane 2: RNA transcripts from
cisplatin-treated DNA templates. c Agarose gel (1 %) demonstrating RT-PCR products (301 bp) from cisplatin-treated DNA templates. M: size marker. Odd
lanes: RT-PCR products from mock DNA templates. Even lanes: RT-PCR products from cisplatin-treated DNA templates. DNA was amplified for 9 (lanes 1
and 2), 12 (lanes 3 and 4), 15 (lanes 5 and 6), 18 (lanes 7 and 8), or 21 (lanes 9 and 10) PCR cycles. Lanes 11 and 12: no RT reaction
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not UV-induced lesions. Only the combination of T7
RNAP transcription and qPCR can detect both cisplatin-
and UV-induced DNA lesions that interfere with tran-
scription. Therefore, our results support the idea analysis
of transcription products can be used to detect damage
in DNA templates, consistent with the model of TCR [7,
25]. Our new method might reveal DNA lesions that
cannot be detected by conventional replication-based
methods and should facilitate research on DNA damage
responses.
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Fig. 9 RT-qPCR analysis of transcripts from cisplatin-treated DNA templates. a Scheme for detecting transcription inhibition from cisplatin-treated
DNA templates (drug/nucleotide ratio = 0.005). b Melting curve of RT-qPCR products from RNA transcripts of cisplatin-treated DNA templates.
Each reaction was run in triplicate. c Amplification plot of RT-qPCR analysis of RNA transcripts of cisplatin-treated DNA templates. Each reaction
was run in triplicate. d Relative fold change of transcripts from mock (set as 1.0) and cisplatin-treated DNA templates. Data show the mean of
three samples ± standard deviation (SD)
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